Initial studies of RotaTeq comprised of studies of the parent strain, various combinations of serotypes and the concept of creating reassortant vaccines. Following positive results from initial ...
A review of RotaTeq (rotavirus vaccine live) clinical trial data revealed higher, though not statistically significantly, KD rates among RotaTeq vaccines than placebo recipients. In June 2007 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback